Elon Musk’s brain device company Neuralink has been approved by the Food and Drug Administration to launch its first clinical trial on humans, the company announced late on Thursday. Neuralink is developing a brain implant that enables people to communicate directly with computers using only their thoughts. Early product development is geared toward people with medical conditions that limit...
Get access to exclusive coverage
Read deeply reported stories from the largest newsroom in tech.
The Briefing cloud ai
Amazon’s Anthropic Deal Signals Cloud Sector Turbulence
You know the cloud industry is in upheaval when industry leader Amazon Web Services has to copy a tactic used by its smaller rivals to compete more effectively. The Amazon unit’s decision on Monday to invest up to $4 billion in AI startup Anthropic, as part of a broader deal in which AWS becomes the startup’s “primary cloud provider,” looks a lot like the type of equity-for-business deals AWS...
Stay in the know
Receive a summary of the day's top tech news—distilled into one email.
Access on the go
View stories on our mobile app and tune into our weekly podcast.
Enjoy a clutter-free experience
Read without any banner ads.
Recent Popular Stories
Exclusive google semiconductors
To Reduce AI Costs, Google Wants to Ditch Broadcom as Its TPU Server Chip Supplier
AI Agenda ai
Nvidia Engineer’s Message to Google AI Researchers: Leave Your Company